Table 5.
Multilevel Nonstructural Component | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Allograft | Autograft (Local) | BMA | DBM | None | Platelet | Synthetic (Ceramic) | rhBMP2 | |||
Cancellous | Osteocel Trinity | Iliac Crest Cancellous | ||||||||
Specialty | ||||||||||
Neurosurgery | 19 (9.5) | 4 (2.0) | 22 (11.1) | 35 (17.6) | 3 (1.5) | 30 (15.1) | 49 (24.6) | 6 (3.0) | 18 (9.0) | 1 (0.5) |
Orthopedics | 35 (8.9) | 4 (1.0) | 110 (28.0) | 58 (14.8) | 6 (1.5) | 35 (8.9) | 114 (29) | 2 (0.5) | 15 (3.8) | 4 (1.0) |
Practice setting | ||||||||||
Academic | 17 (7.5) | 2 (0.9) | 39 (17.2) | 39 (17.2) | 4 (1.8) | 29 (12.8) | 72 (31.7) | 7 (3.1) | 12 (5.3) | 1 (0.4) |
Nonacademic | 37 (10.2) | 6 (1.6) | 93 (25.5) | 53 (14.6) | 6 (1.6) | 36 (9.9) | 91 (25.0) | 1 (0.3) | 20 (5.5) | 4 (1.1) |
Years of practice | ||||||||||
<5 years | 15 (8.2) | 4 (2.2) | 40 (22.0) | 29 (15.9) | 3 (1.6) | 19 (10.4) | 62 (34.1) | 1 (0.5) | 2 (1.1) | 0 (0) |
5-14 years | 17 (7.9) | 2 (0.9) | 49 (22.7) | 30 (13.9) | 3 (1.4) | 21 (9.7) | 56 (25.6) | 6 (2.8) | 21 (9.7) | 3 (1.4) |
≥15 years | 22 (11.3) | 2 (1.0) | 43 (22.1) | 34 (17.4) | 4 (2.1) | 25 (12.8) | 45 (23.1) | 1 (0.5) | 10 (5.1) | 2 (1.0) |
Region | ||||||||||
Europe | 18 (10.9) | 2 (1.2) | 22 (13.3) | 29 (17.6) | 2 (1.2) | 17 (10.3) | 45 (27.3) | 2 (1.2) | 16 (9.7) | 1 (0.6) |
North America | 4 (6.3) | 4 (6.3) | 6 (9.4) | 14 (21.9) | 1 (1.6) | 12 (18.8) | 19 (29.7) | 0 (0) | 1 (1.6) | 1 (1.6) |
Africa/Middle East | 10 (17.5) | 0 (0) | 13 (22.8) | 8 (14.0) | 2 (3.5) | 2 (3.5) | 15 (26.3) | 3 (5.3) | 3 (5.3) | 1 (1.8) |
Asia Pacific | 8 (4.6) | 1 (0.6) | 42 (24.1) | 28 (16.1) | 4 (2.3) | 18 (10.3) | 59 (33.9) | 2 (1.1) | 7 (4.0) | 0 (0) |
Latin America | 14 (10.5) | 1 (0.8) | 49 (36.8) | 14 (10.5) | 1 (0.8) | 16 (12.0) | 25 (18.8) | 1 (0.8) | 6 (4.5) | 2 (1.5) |